Browsing archives for May, 2019

Clinical Trial: CBD Administration Reduces Heroin Cravings

Generic 22 May 2019 | 0 Comments

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Investigators at The Mount Sinai Health System in New York City assessed the effect of CBD versus placebo in 42 drug-abstinent participants with a history of […]

Tagged in , ,

CBD clinical trial results on seizure frequency in dogs ‘encouraging’

Did you know that? 21 May 2019 | 0 Comments

Scientists have found in a small study that 89 percent of dogs who received CBD in the clinical trial had a reduction in the frequency of seizures. Nine dogs were treated with CBD, while seven in a control group were treated with a placebo.

Tagged in

Nevada: Reform Efforts are Still Alive

Generic 21 May 2019 | 0 Comments

Even though cannabis has been recreationally legal in the Battle Born State for nearly two years and Sin City has become a greenish gold mine of legal cannabis, many problems and societal penalties still arise with the use of it; no social consumption lounges being among the most glaring. Yet unlike the consumption lounges, people’s […]

Tagged in , , ,

Massachusetts: State Regulators Grant Initial Approval To Social Use Spaces

Generic 20 May 2019 | 0 Comments

Members of the state’s Cannabis Control Commission have decided to advance plans to regulate social marijuana use facilities. Regulators voted 3 to 2 in favor of the proposal, which seeks to establish a pilot program in up to a dozen self-selected cities throughout the state. However, implementing the plan will require additional legislative action from […]

Tagged in ,

NORML Submits Comments to FDA Ahead of CBD Hearing

Generic 16 May 2019 | 0 Comments

NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. The agency will be taking in person public testimony on Friday, May 31, with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. In its written testimony, […]

Tagged in , , ,